About RDT
Rapid Dose Therapeutics, RDT, is a Canadian life sciences company which provides disruptive proprietary drug delivery technologies designed to improve patient outcomes.
Formed because of a recognized need to move drug delivery to a new level. RDT provides product innovation, production, and consultation to the pharmaceutical and healthcare manufacturing industry.
RDT’s Mission
Board of Directors
Mark UpsdellDirector and Chief Executive Officer
Mr. Upsdell has over 25 years of experience in management, sales and strategic planning. Mr. Upsdell is the Founder and has been a director and the CEO of RDT since its incorporation on May 3rd, 2017. Prior to that, Mr. Upsdell was Director, Global Strategy and Planning of Cisco Systems, Inc. (a high-tech conglomerate) from 2011 to April 2017. Mr. Upsdell was also formerly a sales executive for Hewlett- Packard (a technology company) from January 2000 to November 2011. Mr. Upsdell graduated from Conestoga College in 1982 with a diploma in Business Administration and graduated in 1983 from McMaster University with a M.Sc. in Computer Science.
Peter Thilo Hasler
Director
Mr. Hasler has been an equity analyst for more than 25 years. He is the founder and analyst of Sphene Capital GmbH, which offers high-quality equity and bond research to selected companies. In 2015, he founded Sphaia advisory GmbH, which offers corporate finance and communications services to small- and medium-sized companies. He is a member of the board and lecturer of the DVFA and lecturer with several Munich universities on company valuation and financing as well as company valuation. He is the author of numerous essays and books on company valuation, corporate finance, capital investment and investor relations and regularly publishes columns in the financial media.
John McKimm
Director
Mr. McKimm is currently the Chief Executive Officer of Smart Employee Benefits Inc. (formerly TSXV: SEB) and his experience spans over 35 years of serving as a director and an officer of many public and private companies, where he provided operations, investment banking, and corporate finance expertise. This experience covers a range of sectors, including financial services, healthcare, insurance, computer hardware, software and services, manufacturing, petrochemical, mining, oil and gas, food processing, telecom, waste management, biotechnology, and retail. He has personally identified, negotiated and executed more than 150 individual merger, acquisition and financing transactions, both as a principal and as an agent. Mr. McKimm possesses a deep knowledge in dealing with emerging and growth companies, specifically with respect to providing specialty services in government funding programs, strategic and financial restructurings, mergers and acquisitions, operational and financial restructuring and the arrangement of financings. Mr. McKimm’s experience is global.
Mr. McKimm is a graduate of the University of New Brunswick with a Bachelor of Business Administration, and a graduate of the University of Western Ontario with a Masters of Business Administration and a Bachelor of Laws. Mr. McKimm also has a number of investment industry certifications and designations. He has published on select investment and financial restructuring topics.
Jason Lewis
Director
Mr. Lewis is an entrepreneurial executive with 28+ years of hands-on expertise in growing successful businesses within the healthcare marketing, sales productivity, and software development sectors. His experience is focused in pharmaceutical product launches, marketing, and consultation. Mr. Lewis builds and manages high performance sales, marketing, and channel teams, develops creative business go-to-market strategies in high growth, mid and late stage venture backed and publicly traded companies.
A results-driven marketing leader, known for innovation and a unique mix of strategic, creative, operational and technical abilities — Jason’s dedication to ensuring success for brands is unwavering.
Previous to RDT, Mr. Lewis was founder of PharmaComm and RemoteRep® in Ontario, Canada, Director of International Marketing Apotex, and VP of Marketforce a subsidiary of GSW.
Marisa Cornacchia, RN, COHNC, DOHS, MBA, CRM
Marisa is a Registered Nurse with over two decades of experience in both Critical Care and Occupational Health nursing. Marisa also holds an MBA with a concentration in Project Management, and a Certification in Risk Management from The University of Toronto.
Marisa has worked with several national employers in both private and public sectors to manage projects and develop health care strategies including rehabilitation and mental health programs for several organizations. Marisa has experience with clinic management and program design having lead a successful growth strategy for a national leader in primary care and chronic pain clinics. With two decades of nursing experience combined with an MBA, Marisa provides both clinical and academic health care knowledge. Marisa has experience working with medical professionals and allied health care professionals to develop national programs with multi-disciplinary practices to manage acute care, chronic care, and mental health care.
In her previous role as VP Clinical Operations Marisa was responsible for the overall program implementation of the Health and Wellness division including the overall delivery of program services, clinical and administrative staff, as well as financial and KPI reporting.
As a staff RN at the Hospital for Sick Children for the past 28 years, Marisa maintains a dedicated role as a leader in the care of children and their families, and has developed the skill to manage unpredictable challenges, identify priorities, and develop action plans provide emergency/critical care. Marisa is the recipient of the Robert Saulter Humanitarian Award for the Hospital. The completion of a Masters of Business Administration has provided the learning tools for which to better understand organizational design, structure change management, measure business effectiveness, and project manage IT solutions.
Marisa currently affiliated with the Canadian Institute for Patient Safety, and The American Society for Healthcare Risk Management and sits on the Board of Directors for the Canadian Institute for the Relief of Pain and Disability.
Christine Hrudka
Proposed Director
Ms. Hrudka is a Canadian pharmacist, entrepreneur, leader, public speaker, and advocate for women in business. She owned chain and independent pharmacies, served as Chair of the Canadian Pharmacy Association, and has led the advancement of many critical topics provincially, nationally, and internationally. She is a board member of Pharmacy Association of Saskatchewan, the North American representative of the World Pharmacy Council, and an Ad-hoc member of the Minister Anand COVID-19 Supply Council. She is a director of Avricore Health Inc. (TSXV: AVCR) and previously also served as Director of Pharmapod, Director and committee member of Governance and Compensation, Smart Employee Benefits, Board chair of Aither Ingredient Corporation and Member-at-Large, University of Saskatchewan Senate. She has volunteered for many community boards such as SREDA, YWCA, United Way, and WESK. Christine holds a B.Sc. in Pharmacy (BSP) and a designation from the Institute of Corporate Directors, Designation (ICD.D).
Angela O’Leary
Angela O’Leary is a distinguished leader in the Canadian business landscape, renowned for her entrepreneurial skill and strategic leadership. Her career is highlighted by the successful establishment and growth of several enterprises, which have significantly impacted various sectors and generated substantial revenues. She holds the professional CBAP designation (Certified Business Analysis Professional), accredited by the IIBA, and she is also a certified PROSCI change management practitioner. She graduated from the University of Ottawa with a BA in Women’s Studies. A defining highlight of Angela O’Leary’s career is her ownership and leadership role as CEO of a medical supply company. Under her stewardship, the company achieved remarkable success, particularly in the healthcare sector, with sales reaching into the hundreds of millions. This significant achievement demonstrates O’Leary’s exceptional ability to propel growth and ensure profitability in highly competitive markets.
Her business journey includes founding and leading a staffing and sourcing firm, which was successfully acquired in a private deal, and holding a significant leadership role at a technology company. These roles further highlight her extensive experience and adeptness in business management. O’Leary’s ascent to CEO positions in multiple companies underscores her visionary leadership and strategic thinking. Her commitment to hard work and excellence has been a constant throughout her career.
In addition to her business achievements, O’Leary is deeply committed to philanthropy and societal betterment in Canada. She is a strong advocate for social responsibility, actively engaged in initiatives aimed at dismantling systemic barriers and inequalities across different facets of society, all with the overarching aim of making a significant and positive contribution to Canadian society. Her dedication to these causes is integral to her professional identity and philosophy.
Team Members
DOSE Leadership Team
Mark Upsdell – Founder & CEO
Jason Lewis – SVP Business Development
Doug Hyland – CFO CPA, CA
Consultants & Advisors
Dr. Shammit Kapur, Dentist
Radwan Almofti, PHD Pharmaceutical Sciences
Board Of Directors
Mark Upsdell- Founder & CEO
John McKimm (Independent)
Peter Thilo Hasler (Independent)
Christine Hrudka (Independent)
Angela O’Leary (Independent)
Marisa Cornacchia (Independent)
Medical Advisory Board
Dr. Rick Tytus BSc.Phm, MD, CCFP, FCFP
Dr. James Meschino, DC, MS, ROHP
Dr. Michael Glogauer, Head of Dental Oncology, UHN,
Princess Margaret Cancer Centre, Dental Oncology and Maxillofacial Prosthetics
Nissrine Ghannoum, M.Eng.- Director of Marketing & Communications
Paula MacBeth- Director of Operations